ArticleJournal of medical case reports2025
Early experience with renal autotransplant for renal artery stenosis in a 6-year-old patient with neurofibromatosis type 1: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRenal artery stenosis due to neurofibromatosis type 1 is a known important source of secondary renovascular hypertension in pediatric patients. There are no guidelines on the management of renal artery stenosis in children, and the utility of stents and bypass grafting is limited given small patient size. Renal autotransplant to treat renal artery stenosis in a small pediatric patient may be a viable alternative for treatment and spare the need for nephrectomy. CASE PRESENTATION: In this article, we present a case of renal autotransplant in a 6-year-old, 15.8 kg Nepali patient with neurofibromatosis type 1 with refractory hypertension and high-grade stenosis of the proximal right main renal artery. The patient underwent balloon angioplasty, which failed to dilate the stenosis. He later developed hypertensive urgency and required admission to the pediatric intensive care unit. The patient was not a candidate for repeat angioplasty given the length of the stenotic segment and its tortuosity. Blood pressure was unable to be controlled on multiple antihypertensive agents and the patient eventually developed hypertensive urgency. Therefore, a renal autotransplant of the right kidney was performed after multidisciplinary evaluation. The right renal artery ostium had significant hypertrophied intima involving 50% of its circumference. The kidney was procured in the same fashion as a living kidney donor nephrectomy. The kidney was mobilized in situ, and heparin was administered. The renal artery and renal vein were divided with surgical staplers. The kidney was removed from the patient and moved to the back table. On the back table, the organ was flushed with cold organ preservation solution and vessels inspected. The diseased portion of the right renal artery was resected to the location of no gross intimal thickening. It was judged that there was adequate length of the healthy artery remaining to allow safe reimplantation. The renal artery and vein were reimplanted to the abdominal aorta and inferior vena cava, respectively. The patient tolerated the surgery well, and 2 years postoperatively, he only requires one antihypertensive medication.
conclusionNephrectomy may be favored over renal autotransplant in small pediatric patients due to technical difficulties associated with autotransplant. We demonstrate significant clinical improvement in blood pressure control in a 15.8 kg, 6-year-old pediatric patient after renal autotransplant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.